课题基金 / 基金详情

Cancer-focused Summer Undergraduate Research (CanSUR) Program

Cancer-focused Summer Undergraduate Research (CanSUR) Program
以癌症为重点的暑期本科生研究 (CanSUR) 计划
批准号:
10678931
负责人:
MARK W. JACKSON
金额:
$21.13万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-08-31

项目摘要

项目成果

MARK W. JACKSON的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 自从与癌症的战争开始以来,癌症一直是生物医学研究的主要焦点 1971年的《癌症法案》。尽管有这样的关注,全球每年仍有近800万人死于癌症。帮助 确保国家的生物医学、临床和行为癌症研究队伍保持强大,我们 建议开展以癌症为重点的暑期本科生研究(CanSUR)计划,以 招收来自不同背景的积极进取的本科生,培养他们对 从事癌症研究的职业。CanSuR计划每年将支持32名本科生,招募 来自地区和国家的学院/大学,为期10周,参加癌症研究 与Case综合癌症中心(Case CCC)成员的合作经验。的主要目标 CANSUR计划的目的是:(1)为每个学者提供一个案例的夏季癌症研究经验 成员实验室;(2)培养对生物医学、癌症研究职业机会的了解;以及(3) 提供科学丰富的专业技能课程,帮助他们为下一步的 专注于癌症研究的事业。已经开发了四个主要组成部分来实现这些目标, 包括一周密集的癌症沉浸工作坊,一系列互动的癌症研究讲座 癌症生物学基础、当前癌症治疗方法、癌症研究技术、癌症事业 路径和创新的三维癌症教育模块(称为全息镜头)。我们提出了一种新颖的2- 分层导师结构,包括主要导师(实验室负责人)和初级导师,这将是 负责CanSUR学者在研究环境内的日常培训的负责人。 除了他们个人的研究经验外,我们还开发了一系列科学丰富组件 它们解决了癌症研究中的重要问题,如培养职业习惯,有效 沟通策略,以及了解癌症对个人及其家庭的影响(使用演讲 由患者权益倡导者)。将介绍许多以癌症为重点的职业道路,并指导如何 为特定职业道路的下一步做准备将通过研究生和医学院的招生来提供 董事,已经实现癌症相关职业目标的专业人士,以及目前的实习生。给定 由于我们的目标非常重要,我们已被承诺提供重要的机构支持,并拥有82名教职员工和 关注癌症教育的机构领导准备招聘和培养优秀本科生 这个暑期节目。因此,我们处于有利的地位,将高度上进的本科生转化为 全国下一批癌症研究队伍。
英文摘要
PROJECT SUMMARY Cancer has been a major focus of biomedical research since the war on cancer began with the National Cancer Act of 1971. Despite this focus, nearly 8 million people die of cancer each year, worldwide. To help ensure that the nations’ biomedical, clinical, and behavioral cancer research workforce remains strong, we propose the development of a Cancer-focused Summer Undergraduate Research (CanSUR) Program, to recruit highly motivated undergraduate students from diverse backgrounds and foster their excitement for a career in cancer research. The CanSUR program will support 32 undergraduate scholars each year, recruited from regional and national colleges/universities for a 10-week period, to participate in a cancer research experience with members of the Case Comprehensive Cancer Center (Case CCC). Key objectives of the CanSUR Program are to: (1) provide each scholar with a summer cancer research experience in a Case CCC members lab; (2) foster an understanding of biomedical, cancer research career opportunities and (3) providing scientific enrichment and professional skills curriculum to help prepare them for the next step in a cancer research focused career. Four major components have been developed to meet these objectives, including an Intensive Week 1 Cancer Immersion Workshop, a series of interactive cancer research lectures on the fundamentals of cancer biology, current cancer therapies, cancer research techniques, cancer career paths and innovative 3-dimensional cancer education modules (called the HoloLens). We propose a novel 2- tier mentorship structure that includes both the primary mentor (lab leader), and a junior mentor, which will be the person in charge of the day-to-day training of the CanSUR scholar within the research environment. Beyond their individual research experience, we have developed a series of Scientific Enrichment components which address important issues in cancer research, such as developing professional habits, effective communication strategies, and an appreciation of how cancer impacts individuals and their families (using talks by patient advocates). Numerous cancer-focused career paths will be introduced, and guidance about how to prepare for the next step of a specific career path will be provided by graduate and medical school admissions directors, professionals who have achieved their cancer-related career goals, and current trainees. Given the importance of our objectives, we have been pledged significant institutional support and have 82 faculty and institutional leaders who focus on cancer education prepared to recruit and train outstanding undergraduates in this summer program. As such, we are well-positioned to convert highly-motivated undergraduates into the nation’s next cancer research workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
  • 批准号:
    10704231
  • 项目类别:
  • 资助金额:
    $39.32万
  • 财政年份:
    2022
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
  • 批准号:
    10493939
  • 项目类别:
  • 资助金额:
    $40.09万
  • 财政年份:
    2022
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
  • 批准号:
    10364703
  • 项目类别:
  • 资助金额:
    $40.46万
  • 财政年份:
    2021
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
  • 批准号:
    10576854
  • 项目类别:
  • 资助金额:
    $40.46万
  • 财政年份:
    2021
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
海外基金